Navigation Links
Self-Monitoring of Blood Glucose Highly Effective in Diabetes Care, According to a Special Issue of Diabetes Technology and Therapeutics
Date:5/29/2008

NEW ROCHELLE, N.Y., May 29 /PRNewswire/ -- Subjects with type 1 or type 2 diabetes who self-monitor their blood glucose levels more frequently and use the results to adjust treatment regimens can achieve improved glucose control, according to a collection of state-of-the-art reports that comprise a Special Supplement to the June 2008 issue (Volume 10, Supplement 1) of Diabetes Technology & Therapeutics, a peer-reviewed journal published by Mary Ann Liebert, Inc. (http://www.liebertpub.com). The supplement is available free online at http://www.liebertonline.com/dia

"Increased frequency of self-monitoring of blood glucose (SMBG) has been shown to significantly improve glucose control. SMBG not only complements A1C results, it guides the patient for self-management of diabetes at home on a day-to-day basis," writes Editor-in-Chief, Satish K. Garg, MD, Professor of Medicine and Pediatrics at the University of Colorado at Denver and Health Sciences Center, in a supplement overview.

Spanning the clinical, practical, and economic implications of SMBG, the supplement includes papers probing the technology behind state-of-the-art glucose meters and self-monitoring techniques, SMBG in pregnancy, and SMBG in the Asia-Pacific Region.

Shoba Subramanian, MD, and Irl Hirsch, MD, of the University of Washington, Seattle, review the evidence supporting frequent SMBG, recent advances in glucose meters and SMBG data processing and how it can be applied for more effective type 1 diabetes management, as well as the potential barriers to use of frequent SMBG that limit its applicability, in an article entitled, "The Utility and Recent Advances in Self-Monitoring of Blood Glucose in Type 1 Diabetes."

Focusing on type 2 diabetes, Nalinee Poolsup, PhD, from Silpakorn University, Nakhon-Pathom, Thailand, and Naeti Suksomboon, PharmD, PhD and Warisara Jiamsathit, MScPharm, from Mahidol University, Bangkok, Thailand, conclude that SMBG can yield a significant decrease in HbA1C levels in patients with type 2 diabetes when the results of SMBG are used to adjust therapeutic regimens. They describe the benefits of SMBG in "Systematic Review of the Benefits of Self-Monitoring of Blood Glucose on Glycemic Control in Type 2 Diabetes Patients."

In a forward-looking report entitled, "The Future of Self-Monitored Blood Glucose: Mean Blood Glucose Versus Glycosylated Hemoglobin," Roger Mazze, PhD, from the University of Minnesota Medical School, Minneapolis, emphasizes the importance of SMBG in monitoring diurnal glucose patterns, rather than relying solely on HbA1C or mean glucose levels, which can be misleading indicators of therapeutic efficacy.

Diabetes Technology & Therapeutics is a peer-reviewed journal published bimonthly that covers new technology and new products for the treatment, monitoring, diagnosis, and prevention of diabetes and its complications. Technologies include noninvasive glucose monitoring, implantable continuous glucose sensors, novel routes of insulin administration, genetic engineering, the artificial pancreas, measures of long-term control, computer applications for case management, telemedicine, the Internet, and new medications. Tables of contents and a free sample issue may be viewed online at http://www.liebertpub.com/dia

Mary Ann Liebert, Inc., is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including, Thyroid, Metabolic Syndrome and Related Disorders, Obesity Management, and Journal of Aerosol Medicine and Pulmonary Drug Delivery. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 60 journals, books, and newsmagazines is available at http://www.liebertpub.com

Contact: Vicki Cohn

Mary Ann Liebert, Inc.

(914) 740-2100, ext. 2156

vcohn@liebertpub.com


'/>"/>
SOURCE Diabetes Technology & Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. No association found between vitamin D concentration in blood and risk of prostate cancer
2. International Research Organization Responds to Recent Studies Purporting to Show That Transfusion of Older Red Blood Cells Leads to Greater Risk
3. Enriched Cocoa Improves Blood Flow in Diabetics
4. All Childrens Hospital Achieves ISBT 128 Compliance With Mediwares HCLL Blood Bank System
5. Monitoring blood flow helps improve prostate biopsies, Jefferson researchers report
6. Blood cholesterol levels predict risk of heart disease due to hormone therapy
7. Reducing blockage fails to improve access to the bloodstream for kidney dialysis
8. Home Blood-Pressure Monitoring Recommended
9. Cord Blood America Reports First Quarter Financial Results; Gross Profits Increase
10. Teen Blood Donors More Prone to Complications
11. Study: Doctors Not Always Sure When to Treat Blood Pressure in People With Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2016)... ... 2016 , ... Spring Fertility , the only fertility ... egg freezing, today announced the grand opening of its first location in San ... Fertility offers both fertility preservation (egg, sperm, embryo, and testicular and ovarian tissue ...
(Date:5/5/2016)... ... May 05, 2016 , ... ... Wharton Seminars for Business Journalists , led by the Wharton School’s ... and economic issues.  This one-day program at the Wharton School’s San Francisco ...
(Date:5/5/2016)... ... May 05, 2016 , ... United Benefit Advisors (UBA), ... as the latest addition to its family of Partner Firms. Headquartered in Mount ... wellness, human resources, and health care consumerism specialists. , “Partnering with UBA will ...
(Date:5/5/2016)... ... May 05, 2016 , ... ... Make-A-Wish grants the most heartfelt wishes of these children. The wishes provide ... treatment. President and CEO of Make-A-Wish Mississippi, Brent Wilson said, “In 2016, ...
(Date:5/5/2016)... ... May 05, 2016 , ... Michael Lanteri Agency ... created to assist the people of their local community. The agency pledges to ... community leaders. Their hope is to bring awareness to important local causes with ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... Research and Markets has ... Ischemic Stroke Market and Competitive Landscape Highlights ...      (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ) ... Market and Competitive Landscape Highlights 2016, provides ... products, Acute Ischemic Stroke epidemiology, Acute Ischemic ...
(Date:5/4/2016)... , May 4, 2016 ... addition of the  "Global Actinic Keratosis Market ... to their offering.       (Logo: ... Keratosis Market and Competitive Landscape Highlights 2016, ... products, Actinic Keratosis epidemiology, Actinic Keratosis market ...
(Date:5/3/2016)... 4, 2016 Global Insulin ... profiling 09 key companies and supported with 272 ... in-depth study on the current state of the ... the industry including definitions, classifications, applications and industry ... provided for the international market including development history, ...
Breaking Medicine Technology: